BioLargo, Inc.

BLGO · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$4-$4-$5-$7
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$2$3$2$2
Change in WC-$2-$2-$0$0
Other Non-Cash$0$0-$0$1
Operating Cash Flow-$3-$2-$3-$4
Investing Activities
PP&E Inv.-$1-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$0$0$0-$0
Investing Cash Flow-$1-$0-$0-$0
Financing Activities
Debt Repay.$1$0$0-$0
Stock Issued$3$5$4$5
Stock Repurch.$0$0$0$0
Dividends Paid-$0-$0$0$0
Other Fin. Act.$1$5$4$4
Financing Cash Flow$4$5$4$4
Forex Effect$0-$0-$0-$0
Net Chg. in Cash$0$2$1$0
Supplemental Information
Beg. Cash$4$2$1$1
End Cash$4$4$2$1
Free Cash Flow-$4-$3-$3-$4